BCBP
BCB Bancorp, Inc.
There isn't enough reported data to score BCBP yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BCBP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
BCBP's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCBP.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BCBP PE Valuation
BCBP has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 19x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BCBP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect BCBP to return to profit, with revenue growing. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BCBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.47 | — |
| Q3 2026 | -$8.24 | -13833% |
| Q2 2026 | -$1.10 | -650% |
| Q1 2026 | -$0.07 | -144% |
| Q4 2025 | -$0.84 | -185% |
| Q3 2025 | $0.06 | -95% |
| Q2 2025 | $0.20 | -83% |
| Q1 2025 | $0.16 | -90% |
| Q4 2024 | $0.99 | -42% |
BCBP has swung to a loss: it lost $8.24 per share over the past year, after a profit the year before.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has the edge over BCBP on earnings, with more consistent year-over-year improvement.
BCBP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $27.8M | +5% |
| Q2 2026 | $22.9M | -9.1% |
| Q1 2026 | $24.9M | +4.8% |
| Q4 2025 | $26.2M | +13% |
| Q3 2025 | $26.5M | +1.1% |
| Q2 2025 | $25.2M | +23% |
| Q1 2025 | $23.8M | -5.8% |
| Q4 2024 | $23.1M | -15% |
BCBP's revenue has held roughly level: $28M last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -392% | -414 points |
| Q2 2026 | -80% | -100 points |
| Q1 2026 | 26% | +76 points |
| Q4 2025 | -67% | -87 points |
| Q3 2025 | 22% | -14 points |
| Q2 2025 | 20% | +0.4 points |
| Q1 2025 | -49% | -82 points |
| Q4 2024 | 20% | -12 points |
BCBP's operating margin was −392% last quarter, down 414 points from the same quarter a year ago, near the bottom of its range since 2019.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over BCBP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN has the edge over BCBP on profitability, with a higher operating margin.
BCBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.7M | -44% |
| Q2 2026 | $9.3M | -8.2% |
| Q1 2026 | $4.9M | +4% |
| Q4 2025 | $11.5M | +69% |
| Q3 2025 | $8.5M | -81% |
| Q2 2025 | $10.2M | +26% |
| Q1 2025 | $4.7M | -42% |
| Q4 2024 | $6.8M | +1339% |
BCBP has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BCBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +1.8M shares |
| 1 year | +11% | +1.9M shares |
| 3 years | +14% | +2.3M shares |
| 5 years | +11% | +1.9M shares |
| Available history | +17% | +2.7M shares |
BCBP has 19M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $1.3M |
| Q1 2023 | $2.6M |
| Q4 2022 | $1.4M |
| Q3 2022 | $1.2M |
| Q2 2022 | $756,000 |
| Q1 2022 | $8,000 |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over BCBP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BCBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 19.3x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 17.3x | High |
| Q3 2024 | 1.7x | Healthy |
| Q2 2024 | 0.8x | Very low |
| Q1 2024 | 0.6x | Very low |
BCBP has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BCBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 60.5 | Neutral |
BCBP's weekly RSI is 52 (neutral) and its Stochastic is 60 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BCBP PE vs Financial Services Sector
| Metric | BCBP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
BCBP has no meaningful PE right now: it lost money over the past year.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
BCBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.68 | 5.6% above |
| 20 week MA | $9.09 | 0.9% above |
| 50 week MA | $9.06 | 1.2% above |
| 100 week MA | $9.09 | 0.9% above |
| 200 week MA | $10.6 | 13% below |
BCBP has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BCBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.9 | $10.8 | -22% |
| 2021 | $10.8 | $15.6 | +45% |
| 2022 | $15.6 | $18.0 | +16% |
| 2023 | $18.0 | $12.9 | -29% |
| 2024 | $12.9 | $11.7 | -9.3% |
| 2025 | $11.7 | $8.27 | -29% |
| 2026 YTD | $8.27 | $9.17 | +11% |
BCBP has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.